Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD.

scientific article published in November 2009

Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/EJI.200939432
P698PubMed publication ID19750478
P5875ResearchGate publication ID26808549

P50authorBernard MalissenQ2898273
Immo PrinzQ38322264
Christian KoeneckeQ42873577
Adrien KissenpfennigQ60731702
Reinhold ForsterQ63958748
Niklas CzelothQ125340564
P2093author name stringSusanne Schmitz
Arnold Ganser
Jochen Huehn
Anja Bubke
P2860cites workCD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent mannerQ24656647
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3Q24672849
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7Q28591451
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acidQ29619479
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemiaQ33629928
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulationQ34580976
Antigen-induced regulatory T cellsQ35693709
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantationQ36370863
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospectsQ36826059
In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host diseaseQ36843821
Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cellsQ36868786
Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticityQ37100901
The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell functionQ37143002
Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.Q40565739
Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturationQ42861996
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantationQ44408941
Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantationQ44935495
Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6.Q45998381
DNA methylation controls Foxp3 gene expressionQ46391168
Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cellsQ46798648
Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions.Q51765584
Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.Q51770870
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.Q53589050
In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation toleranceQ79143624
From vanilla to 28 flavors: multiple varieties of T regulatory cellsQ80141724
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cellsQ81357564
P433issue11
P407language of work or nameEnglishQ1860
P304page(s)3091-3096
P577publication date2009-11-01
P1433published inEuropean Journal of ImmunologyQ5412727
P1476titleAlloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD
P478volume39